about
Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sitesAnti-neoplastic activity of two flavone isomers derived from Gnaphalium elegans and Achyrocline bogotensisDesign and optimization of PLGA-based diclofenac loaded nanoparticlesEffect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticlesNon-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.Quantification of two isomeric flavones in rat colon tissue using reverse phase high performance liquid chromatography.Pharmacogenetics of nonsteroidal anti-inflammatory drugs.Plagiarism among applicants for faculty positions.Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam.Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats.Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependentDevelopment of reversed-phase high performance liquid chromatography methods for quantification of two isomeric flavones and the application of the methods to pharmacokinetic studies in ratsOpioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and ChildrenHIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study
P50
Q28478551-AD14F6BB-01AA-4B13-8DA3-103B0863F142Q28480937-1D3B4827-837F-419F-9C7B-638845585BA6Q28539253-85C02B9F-69B9-4E9F-B1F6-AE2E1A46F874Q28542696-18DAE4DC-DDC6-41BE-AD4F-2AF677E15A24Q36233306-743A50D1-934A-4177-B0C3-129162CF7446Q36243189-F35111F6-353D-426E-9A9D-E708207F8F7AQ38050316-2AC1B09F-3AFC-4A44-BAD2-1E841D49B2A8Q43080468-7139FB61-407B-41D5-A092-FB3EE782C3DEQ44474442-F9934CF7-DAF7-4953-9FC4-D5D124096C54Q46698989-7DD99E7D-9538-4B23-9864-06D3D4AC8FC0Q52590502-ABA77E71-E644-45C8-836B-E7D4FD02D876Q54433772-E48EDA2A-6382-41A2-8F2B-EC406B00BE5DQ79142152-DD534A15-AB42-4C1C-A3AB-DC33A74AD093Q85913761-DE4ECD86-C7B0-4DAA-AD78-6B0503D64519Q90060539-FE211642-BB16-4648-B04F-57875D5CF368Q90954642-6E76C95B-564F-4CE6-9565-4D32ABB1DA46
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
S Harirforoosh
@ast
S Harirforoosh
@en
S Harirforoosh
@es
S Harirforoosh
@nl
type
label
S Harirforoosh
@ast
S Harirforoosh
@en
S Harirforoosh
@es
S Harirforoosh
@nl
prefLabel
S Harirforoosh
@ast
S Harirforoosh
@en
S Harirforoosh
@es
S Harirforoosh
@nl
P106
P1153
8516657200
P31
P496
0000-0002-2631-3756